Article: Cardiac Dimensions[R] Inc. Receives CE Mark for CARILLON[TM] Mitral Contour System[TM].

Company Looks Ahead Towards Commercialization Options for Europe

KIRKLAND, Wash. -- Cardiac Dimensions[R], Inc. today announced that on January 26th it received the CE Mark approval for its CARILLON[TM] Mitral Contour System[TM] from KEMA Quality B.V. -- a European Union Notified Body from the Netherlands. The CARILLON[TM] system is a percutaneous treatment for functional mitral regurgitation (FMR). The CE Mark approval is an important milestone for Cardiac Dimensions, allowing the company to market the product in countries that accept CE Marking -- primarily Europe. Cardiac Dimensions is now developing plans for commercialization in Europe.

Prior to the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!